Rituximab biosimilars: introduction into clinical practice

被引：2
|
作者：
Makita, Shinichi [1 ]
Tobinai, Kensei [1 ]
机构：
[1] Natl Canc Ctr, Dept Hematol, Chuo Ku, Tokyo 1040045, Japan
来源：
LANCET HAEMATOLOGY | 2017年 / 4卷 / 08期
关键词：
LYMPHOMA;
D O I：
10.1016/S2352-3026(17)30124-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E342 / E343
页数：2
相关论文
共 50 条
  • [41] RITUXIMAB IN LUPUS NEPHRITIS. REAL CLINICAL PRACTICE
    Ramos Giraldez, C.
    Velloso Feijoo, M. L.
    Rodriguez Montero, S.
    Marenco, J. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1489 - 1489
  • [42] Rituximab maintenance therapy of follicular lymphoma in clinical practice
    Duehrsen, Ulrich
    Broszeit-Luft, Stefanie
    Dieing, Annette
    Lueck, Andreas
    Porowski, Piotr
    Reiser, Marcel
    Schwinger, Ulrike
    Klawitter, Sandra
    Krumm, Katja
    Jentsch-Ullrich, Kathleen
    CANCER MEDICINE, 2018, 7 (07): : 2903 - 2912
  • [43] Chronic lymphocytic leukaemia: rituximab 'will change clinical practice'
    Pinn, Stephen
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (02) : 70 - 70
  • [44] Biosimilars in the practice of modern oncologist
    Shevchuk, I. M.
    Kalpinskiy, A. S.
    ONKOUROLOGIYA, 2023, 19 (04): : 176 - 188
  • [45] BIOSIMILARS: OUT OF THE LABORATORY AND INTO PRACTICE
    Galloway, James
    RHEUMATOLOGY, 2015, 54 : 21 - 21
  • [46] Low-molecular-weight heparin biosimilars: potential implications for clinical practice
    Nandurkar, H.
    Chong, B.
    Salem, H.
    Gallus, A.
    Ferro, V.
    McKinnon, R.
    INTERNAL MEDICINE JOURNAL, 2014, 44 (05) : 497 - 500
  • [47] Use of Biosimilars in Clinical Practice: A Swedish National Register-Based Assessment
    Di Giuseppe, Daniela
    Frisell, Thomas
    Ernestam, Sofia
    D'Elia, Helena Forsblad
    Lindqvist, E.
    Lindstrom, Ulf
    Askling, Johan
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [48] TO WHAT EXTENT ARE THE LEARNINGS FROM THE INTRODUCTION OF BIOSIMILARS IN INFLAMMATORY DISEASES TRANSFERABLE TO THE FUTURE INTRODUCTION OF BIOSIMILARS IN ONCOLOGY?
    Klebba, S.
    Makin, D.
    Teale, C. W.
    VALUE IN HEALTH, 2016, 19 (07) : A753 - A753
  • [49] Comparison of Adverse Event Profiles of Rituximab, Rituximab Hycela and Rituximab Biosimilars: A Real-World Pharmacovigilance Database Analysis
    Keerty, Dinesh
    Ananthaneni, Anil
    Ramadas, Poornima
    Master, Samip R.
    BLOOD, 2022, 140 : 13196 - 13197
  • [50] BIOFEEDBACK IN CLINICAL-PRACTICE - INTRODUCTION
    STROEBEL, CF
    PSYCHIATRIC ANNALS, 1981, 11 (03) : 84 - 85
12345